Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
simAbs
Diepenbeek, Flanders, Belgiumsimabs.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
simAbs has developed a proprietary continuous biomanufacturing platform enabling fast, flexible, and cost-effective production of high-quality biologics. Their technology supports the manufacture of monoclonal antibodies and other advanced modalities with improved consistency and reduced costs compared to traditional batch processes. The company recently launched a new GMP cleanroom facility in Belgium to expand its capabilities in advanced bio-manufacturing. No direct clinical results are reported as they are primarily a service/platform provider.
- Therapeutic areas
- Other
- Modalities
- Monoclonal antibodies (mAbs)Bispecific antibodiesFabsAntibody-drug conjugates (ADC)NanobodiesViral vectors
- Industry
- Contract Manufacturing Organization
02
Partnerships
Sealantium Medical – partnership for shared GMP cleanroom facility at Bioville incubator in Diepenbeek, BelgiumOther partnerships with industry clients are referenced but not named specifically.
Beyond the preview
Go deeper on simAbs.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on simAbs.